查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1596769

基质血管成分市场：依产品、应用和最终用途 – 2025-2030 年全球预测

Stromal Vascular Fraction Market by Product (Aspiration, Isolation, Transfer), Application (Cosmetic, Orthopedic, Soft Tissue), End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年基质血管成分市场价值为37144万美元，预计2024年将达到51694万美元，复合年增长率为39.65%，到2030年将达到384895万美元。

基质血管成分（SVF）是指源自脂肪组织的一组细胞，含有丰富的再生细胞，如间质干细胞、内皮细胞和免疫细胞。 SVF 的范围涵盖其在再生医学、美容学以及在治疗各种疾病中的潜在应用的重要作用。对 SVF 的需求在于其透过其丰富的细胞成分促进癒合和组织再生的能力。它具有广泛的应用，包括用于脂肪移植和组织增强的美容医学、促进关节再生的整形外科手术以及被认为有望促进心肌再生的心臟病学。最终用途范围主要涵盖医疗机构、研究机构和整容手术中心。慢性疾病患者数量的增加、医疗基础设施的进步以及对高效微创治疗解决方案的需求不断增长推动了市场成长。最近的趋势包括使用 SVF 开发神经退化性疾病的治疗方法并将其应用扩展到新的治疗领域。希望利用这些机会的研究人员包括投资使用 SVF 的新治疗方法的研究、加强生物技术公司和医疗保健提供者之间的合作以及提高监管合规性以简化市场准入。

主要市场统计
基准年[2023] 37144万美元
预测年份 [2024] 51694万美元
预测年份 [2030] 38.4895亿美元
复合年增长率（%） 39.65%

然而，挑战依然存在，包括因严格的安全标准和不同地区的合规要求而导致的监管障碍。此外，SVF 治疗还存在一些局限性，例如成本高、医疗保健提供者和患者缺乏认识和理解。改进 SVF 萃取技术和配製人工支架材料以增强细胞输送和整合的创新已经成熟。优化 SVF 细胞储存和运输系统的研究也有望实现业务成长。市场是动态的，其特点是快速的技术进步和不断变化的监管环境，要求企业保持敏捷性和适应性，以维持成长和创新。

市场动态：揭示快速发展的基质血管成分市场的关键市场洞察

供需的动态交互作用正在改变基质血管成分市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 再生医学临床前和临床研究的增加
    • 骨关节炎和软骨再生等各种疾病的手术数量增加
    • 烧烫伤和皮肤病增加
  • 市场限制因素
    • SVF手术器械成本高
  • 市场机会
    • 技术创新为SVF推出新产品
    • 持续策略投资以有效管理静脉注射
  • 市场挑战
    • 技术纯熟劳工短缺和产品召回

波特的五力：驾驭基质血管成分市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解基质血管成分市场的外部影响

外部宏观环境因素在塑造基质血管成分市场的表现动态方面发挥关键作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解基质血管成分市场的竞争格局

对基质血管成分市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位基质血管成分市场供应商的绩效评估

FPNV定位矩阵是评估基质血管成分市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划基质血管成分市场的成功之路

基质血管成分市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 增加再生医学临床前和临床研究的调查
      • 骨关节炎、软骨再生等各种疾病的手术增多
      • 烧烫伤和皮肤病增加
    • 抑制因素
      • SVF手术器械高成本
    • 机会
      • 技术创新，发布SVF新产品
      • 持续策略投资以有效管理静脉输液
    • 任务
      • 技术纯熟劳工短缺和产品召回
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章基质血管成分市场：副产品

  • 慾望
  • 分离
  • 转移

第七章基质血管成分市场：依应用分类

  • 化妆品
  • 整形外科
  • 软组织

基质血管成分市场：依最终用途

  • 医院
  • 专科诊所
  • 干细胞库/实验室

第九章北美和南美基质血管成分市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区基质血管成分市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲/中东/非洲基质血管成分市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Cytori Therapeutics Inc.
  • Hawaii Angels
  • Human Med AG
  • InGeneron, Inc.
  • Tissue Genesis
Product Code: MRR-9B479F385089

The Stromal Vascular Fraction Market was valued at USD 371.44 million in 2023, expected to reach USD 516.94 million in 2024, and is projected to grow at a CAGR of 39.65%, to USD 3,848.95 million by 2030.

Stromal Vascular Fraction (SVF) refers to a cluster of cells derived from adipose tissue, containing a rich assortment of regenerative cells, including mesenchymal stem cells, endothelial cells, and immune cells. The scope of SVF encompasses its significant role in regenerative medicine, aesthetics, and potentially, therapeutic applications for various diseases. The necessity of SVF springs from its capability to promote healing and tissue regeneration due to its rich cellular components. Applications are widespread, particularly in aesthetic medicine for fat grafting and tissue augmentation, orthopedics to encourage joint regeneration, and cardiology, where it has shown promise in myocardial regeneration. End-use scope primarily spans healthcare facilities, research institutes, and cosmetic surgery centers. Market growth is driven by increasing cases of chronic diseases, advancements in healthcare infrastructure, and an escalating demand for efficient, minimally invasive therapeutic solutions. Recent opportunities lie in harnessing SVF for developing treatments for neurodegenerative disorders and expanding its application across new therapeutic domains. Recommendations to leverage these opportunities include investing in research for novel SVF-based therapies, enhancing collaborations between biotech companies and healthcare providers, and focusing on regulatory compliance to ease market entry.

KEY MARKET STATISTICS
Base Year [2023] USD 371.44 million
Estimated Year [2024] USD 516.94 million
Forecast Year [2030] USD 3,848.95 million
CAGR (%) 39.65%

However, challenges persist such as regulatory hurdles due to stringent safety standards and varying compliance requirements across regions. Additionally, the market faces limitations like the high cost of SVF therapy procedures and a potential lack of awareness and understanding among healthcare providers and patients. Innovations are ripe in improving SVF extraction techniques and formulating artificial scaffold materials that enhance cell delivery and integration. Research in optimizing storage and transportation systems for SVF cells also promises business growth. The market is dynamic, characterized by rapid technological advancements and an evolving regulatory landscape, necessitating companies to stay agile and adaptable to sustain growth and innovation.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Stromal Vascular Fraction Market

The Stromal Vascular Fraction Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing research in pre-clinical and clinical investigations for regenerative medicine
    • Rising surgeries for different diseases, including osteoarthritis and cartilage regeneration
    • Growing cases of burn and skin diseases
  • Market Restraints
    • High costs of surgical devices for SVF
  • Market Opportunities
    • Technological innovations for new product launches for SVF
    • Ongoing strategic investment for the effective management of intravenous infusion
  • Market Challenges
    • Lack of skilled labor and product recalls

Porter's Five Forces: A Strategic Tool for Navigating the Stromal Vascular Fraction Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Stromal Vascular Fraction Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Stromal Vascular Fraction Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Stromal Vascular Fraction Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Stromal Vascular Fraction Market

A detailed market share analysis in the Stromal Vascular Fraction Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Stromal Vascular Fraction Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Stromal Vascular Fraction Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Stromal Vascular Fraction Market

A strategic analysis of the Stromal Vascular Fraction Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Stromal Vascular Fraction Market, highlighting leading vendors and their innovative profiles. These include Cytori Therapeutics Inc., Hawaii Angels, Human Med AG, InGeneron, Inc., and Tissue Genesis.

Market Segmentation & Coverage

This research report categorizes the Stromal Vascular Fraction Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Aspiration, Isolation, and Transfer.
  • Based on Application, market is studied across Cosmetic, Orthopedic, and Soft Tissue.
  • Based on End-Use, market is studied across Hospitals, Specialty Clinics, and Stem Cell Banks/Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing research in pre-clinical and clinical investigations for regenerative medicine
      • 5.1.1.2. Rising surgeries for different diseases, including osteoarthritis and cartilage regeneration
      • 5.1.1.3. Growing cases of burn and skin diseases
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of surgical devices for SVF
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological innovations for new product launches for SVF
      • 5.1.3.2. Ongoing strategic investment for the effective management of intravenous infusion
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled labor and product recalls
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Stromal Vascular Fraction Market, by Product

  • 6.1. Introduction
  • 6.2. Aspiration
  • 6.3. Isolation
  • 6.4. Transfer

7. Stromal Vascular Fraction Market, by Application

  • 7.1. Introduction
  • 7.2. Cosmetic
  • 7.3. Orthopedic
  • 7.4. Soft Tissue

8. Stromal Vascular Fraction Market, by End-Use

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Specialty Clinics
  • 8.4. Stem Cell Banks/Laboratories

9. Americas Stromal Vascular Fraction Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Stromal Vascular Fraction Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Stromal Vascular Fraction Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Cytori Therapeutics Inc.
  • 2. Hawaii Angels
  • 3. Human Med AG
  • 4. InGeneron, Inc.
  • 5. Tissue Genesis

LIST OF FIGURES

  • FIGURE 1. STROMAL VASCULAR FRACTION MARKET RESEARCH PROCESS
  • FIGURE 2. STROMAL VASCULAR FRACTION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS STROMAL VASCULAR FRACTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS STROMAL VASCULAR FRACTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES STROMAL VASCULAR FRACTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES STROMAL VASCULAR FRACTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC STROMAL VASCULAR FRACTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC STROMAL VASCULAR FRACTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA STROMAL VASCULAR FRACTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA STROMAL VASCULAR FRACTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. STROMAL VASCULAR FRACTION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. STROMAL VASCULAR FRACTION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. STROMAL VASCULAR FRACTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. STROMAL VASCULAR FRACTION MARKET DYNAMICS
  • TABLE 7. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY ASPIRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY ISOLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY TRANSFER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY COSMETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY SOFT TISSUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY STEM CELL BANKS/LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS STROMAL VASCULAR FRACTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES STROMAL VASCULAR FRACTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC STROMAL VASCULAR FRACTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA STROMAL VASCULAR FRACTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 146. STROMAL VASCULAR FRACTION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. STROMAL VASCULAR FRACTION MARKET, FPNV POSITIONING MATRIX, 2023